|
ISRCTN
|
ISRCTN27827390
|
|
DOI
|
10.1186/ISRCTN27827390
|
|
ClinicalTrials.gov identifier
|
|
|
EudraCT number
|
|
|
Public title
|
Carboplatin versus etoposide/cisplatin for advanced metastatic seminoma
|
|
Scientific title
|
|
|
Acronym
|
N/A
|
|
Serial number at source
|
TE12
|
|
Study hypothesis
|
Compare the efficacy of carboplatin with a combination of etoposide and cisplatin in the treatment of advanced metastatic seminoma.
|
|
Lay summary
|
|
|
Ethics approval
|
Not provided at time of registration
|
|
Study design
|
Randomised controlled trial
|
|
Countries of recruitment
|
United Kingdom
|
|
Disease/condition/study domain
|
Cancer
|
|
Participants - inclusion criteria
|
Histologically verified testicular/extra-gonadal pure seminoma
|
|
Participants - exclusion criteria
|
Previous chemotherapy.
|
|
Anticipated start date
|
01/08/1990
|
|
Anticipated end date
|
31/12/1995
|
|
Status of trial
|
Completed |
|
Patient information material
|
|
|
Target number of participants
|
112
|
|
Interventions
|
Arm 1 - 4 cycles of carboplatin.
Arm 2 - 4 cycles of cisplatin/etoposide.
|
|
Primary outcome measure(s)
|
Progression-free survival
|
|
Secondary outcome measure(s)
|
Response, survival, toxicity.
|
|
Sources of funding
|
Medical Research Council (UK)
|
|
Trial website
|
|
|
Publications
|
Results on http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11104556
|
|
Contact name
|
Miss
Sharon
Naylor
|
|
Address
|
MRC Clinical Trials Unit
222 Euston Road
|
|
City/town
|
London
|
|
Zip/Postcode
|
NW1 2DA
|
|
Country
|
United Kingdom
|
|
Email
|
|
|
Sponsor
|
Medical Research Council (MRC) (UK)
|
|
Address
|
20 Park Crescent
|
|
City/town
|
London
|
|
Zip/Postcode
|
W1B 1AL
|
|
Country
|
United Kingdom
|
|
Tel
|
+44 (0)20 7636 5422
|
|
Fax
|
+44 (0)20 7436 6179
|
|
Email
|
clinical.trial@headoffice.mrc.ac.uk
|
|
Sponsor website:
|
http://www.mrc.ac.uk
|
|
Date applied
|
28/02/2001
|
|
Last edited
|
11/09/2007
|
|
Date ISRCTN assigned
|
28/02/2001
|
